TY - JOUR
T1 - European Association of Urology Guidelines on the Diagnosis and Management of Female Non-neurogenic Lower Urinary Tract Symptoms. Part 1
T2 - Diagnostics, Overactive Bladder, Stress Urinary Incontinence, and Mixed Urinary Incontinence
AU - Nambiar, Arjun K.
AU - Arlandis, Salvador
AU - Bø, Kari
AU - Cobussen-Boekhorst, Hanny
AU - Costantini, Elisabetta
AU - de Heide, Monica
AU - Farag, Fawzy
AU - Groen, Jan
AU - Karavitakis, Markos
AU - Lapitan, Marie Carmela
AU - Manso, Margarida
AU - Arteaga, Serenella Monagas
AU - Riogh, Aisling Nic An
AU - O'Connor, Eabhann
AU - Omar, Muhammad Imran
AU - Peyronnet, Benoit
AU - Phé, Veronique
AU - Sakalis, Vasileios I.
AU - Sihra, Néha
AU - Tzelves, Lazaros
AU - van Poelgeest-Pomfret, Mary Lynne
AU - van den Bos, Tine W.L.
AU - van der Vaart, Huub
AU - Harding, Christopher K.
N1 - Copyright © 2022 European Association of Urology. All rights reserved.
PY - 2022/7
Y1 - 2022/7
N2 - Context: Female lower urinary tract symptoms (LUTS) are a common presentation in urological practice. Thus far, only a limited number of female LUTS conditions have been included in the European Association of Urology (EAU) guidelines compendium. The new non-neurogenic female LUTS guideline expands the remit to include these symptoms and conditions. Objective: To summarise the diagnostic section of the non-neurogenic female LUTS guideline and the management of female overactive bladder (OAB), stress urinary incontinence (SUI), and mixed urinary incontinence (MUI). Evidence acquisition: New literature searches were carried out in September 2021 and evidence synthesis was conducted using the modified GRADE criteria as outlined for all EAU guidelines. A new systematic review (SR) on OAB was carried out by the panel for the purposes of this guideline. Evidence synthesis: The important considerations for informing guideline recommendations are presented, along with a summary of all the guideline recommendations. Conclusions: Non-neurogenic female LUTS are an important cause of urological dysfunction. Initial evaluation, diagnosis, and management should be carried out in a structured and logical fashion based on the best available evidence. This guideline serves to present this evidence to health care providers in an easily accessible and digestible format. Patient summary: This report summarises the main recommendations from the European Association of Urology guideline on symptoms and diseases of the female lower urinary tract (bladder and urethra) not associated with neurological disease. We cover recommendations related to diagnosis of these conditions, as well as the treatment of overactive bladder, stress urinary incontinence, and mixed urinary incontinence.
AB - Context: Female lower urinary tract symptoms (LUTS) are a common presentation in urological practice. Thus far, only a limited number of female LUTS conditions have been included in the European Association of Urology (EAU) guidelines compendium. The new non-neurogenic female LUTS guideline expands the remit to include these symptoms and conditions. Objective: To summarise the diagnostic section of the non-neurogenic female LUTS guideline and the management of female overactive bladder (OAB), stress urinary incontinence (SUI), and mixed urinary incontinence (MUI). Evidence acquisition: New literature searches were carried out in September 2021 and evidence synthesis was conducted using the modified GRADE criteria as outlined for all EAU guidelines. A new systematic review (SR) on OAB was carried out by the panel for the purposes of this guideline. Evidence synthesis: The important considerations for informing guideline recommendations are presented, along with a summary of all the guideline recommendations. Conclusions: Non-neurogenic female LUTS are an important cause of urological dysfunction. Initial evaluation, diagnosis, and management should be carried out in a structured and logical fashion based on the best available evidence. This guideline serves to present this evidence to health care providers in an easily accessible and digestible format. Patient summary: This report summarises the main recommendations from the European Association of Urology guideline on symptoms and diseases of the female lower urinary tract (bladder and urethra) not associated with neurological disease. We cover recommendations related to diagnosis of these conditions, as well as the treatment of overactive bladder, stress urinary incontinence, and mixed urinary incontinence.
KW - Conservative management
KW - Diagnostics
KW - European Association of Urology guidelines
KW - Female lower urinary tract symptoms
KW - Mixed urinary incontinence
KW - Overactive bladder
KW - Pharmacological management
KW - Stress urinary incontinence
KW - Surgical management
KW - Urinary incontinence
UR - http://www.scopus.com/inward/record.url?scp=85125126549&partnerID=8YFLogxK
U2 - 10.1016/j.eururo.2022.01.045
DO - 10.1016/j.eururo.2022.01.045
M3 - Review article
C2 - 35216856
AN - SCOPUS:85125126549
SN - 0302-2838
VL - 82
SP - 49
EP - 59
JO - European Urology
JF - European Urology
IS - 1
ER -